BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Drug Development

  Immunomedics, Inc.'s Milatuzumab Receives FDA Orphan Drug Designation for Therapy of Multiple Myeloma

  March 18, 2008

   · 

  5 min read
• Alimera Sciences Closes $30 Million in Series C Financing, Increasing Stake in Medidur(TM) FA

  March 18, 2008

   · 

  3 min read
• Drug Development

  BioNumerik Pharmaceuticals, Inc. and ASKA Pharmaceutical Announce Results from Phase III Clinical Trial of Tavocept(TM)

  March 18, 2008

   · 

  7 min read
• Drug Development

  Ardea Biosciences, Inc. Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load

  March 18, 2008

   · 

  5 min read
• Deals

  QLT Inc. to Divest Acne Treatment Following FDA Ruling

  March 18, 2008

   · 

  1 min read
• Drug Development

  TorreyPines Therapeutics, Inc. Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia

  March 18, 2008

   · 

  5 min read
• Drug Development

  Cytopia Limited Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders Clinical Study

  March 18, 2008

   · 

  3 min read
• Opko Health, Inc. Announces Issuance of U.S. Patent

  March 18, 2008

   · 

  4 min read
• Business

  NeoGenomics, Inc. Announces Results for the Fourth Quarter and Full Year FY 2007

  March 18, 2008

   · 

  8 min read
• Spectral Diagnostics Announces New Findings on the Effectiveness of EAA(TM)/Toraymyxin(TM)

  March 18, 2008

   · 

  2 min read